Boys should be given HPV jab, says vaccine committee

by Cancer Research UKHuman papillomavirus (HPV) vaccine. Credit:Wikimedia Commons/CC BY-SA 2.0It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in t

Updated on: May 11,2024 6

Boys should be given HPV jab, says vaccine committee

by Cancer Research UKHuman papillomavirus (HPV) vaccine. Credit:Wikimedia Commons/CC BY-SA 2.0It's nearly a decade since the human papillomavirus (HPV) vaccine was first introduced in t

Updated on:May 11,2024 6

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on: March 21,2024 14

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on:March 21,2024 14

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on: July 30,2024 0

New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment

byUniversity of South AustraliaSchematic of forces acting on cells in inertial microfluidics. Credit:Cytotherapy(2024). DOI: 10.1016/j.jcyt.2024.05.005Researchers from the University

Updated on:July 30,2024 0

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on: January 11,2024 15

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on:January 11,2024 15

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on: February 20,2024 11

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on:February 20,2024 11

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on: June 14,2025 0

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on:June 14,2025 0

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le

Updated on: January 30,2024 19

Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment

by Saint Louis UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI157738Though chemotherapy can be lifesaving, the cancer treatment often le

Updated on:January 30,2024 19

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on: December 28,2023 10

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on:December 28,2023 10

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on: January 16,2024 12

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on:January 16,2024 12

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on: April 28,2024 0

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on:April 28,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024 0

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024 20

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024 20